FR940328-0-00011 FR940328-0-00005 21 CFR Parts 510 and 522 Animal Drugs, Feeds, and Related Products; Euthasol TM Euthanasia Solution AGENCY: Food and Drug Administration, HHS. ACTION: Final rule. SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an abbreviated new animal drug application (ANADA) filed by Delmarva Laboratories, Inc. The ANADA provides for intravenous or intracardiac use of Euthasol TM , a generic euthanasia solution containing pentobarbital sodium 390 milligrams per milliliter (mg/mL) and phenytoin sodium 50 mg/mL, for canine euthanasia. EFFECTIVE DATE: March 28, 1994. FOR FURTHER INFORMATION CONTACT: Larry D. Rollins, Center for Veterinary Medicine (HFV&hyph;110), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301&hyph;594&hyph;1612. SUPPLEMENTARY INFORMATION: Delmarva Laboratories, Inc., P.O. Box 525, Midlothian, VA 23113, is sponsor of ANADA 200&hyph;071 which provides for the use of Euthasol TM , a generic euthanasia solution containing pentobarbital sodium 390 mg/mL and phenytoin sodium 50 mg/mL, for intravenous or intracardiac use for humane, painless, and rapid euthanasia of dogs. Approval of Delmarva Laboratories' ANADA 200&hyph;071 for Euthasol TM Euthanasia Solution (pentobarbital sodium 390 mg/mL and phenytoin sodium 50 mg/mL) is as a generic copy of Schering's NADA 119&hyph;807 for Beuthanasia ® -D Special Solution (pentobarbital sodium 390 mg/mL and phenytoin sodium 50 mg/mL). The ANADA is approved as of February 24, 1994, and the regulations in 21 CFR 522.900 are amended to reflect the approval. The basis for approval is discussed in the freedom of information summary. In accordance with the freedom of information provisions of part 20 (21 CFR part 20) and §514.11(e)(2)(ii) (21 CFR 514.11(e)(2)(ii)), a summary of safety and effectiveness data and information submitted to support approval of this application may be seen in the Dockets Management Branch (HFA&hyph;305), Food and Drug Administration, rm. 1&hyph;23, 12420 Parklawn Dr., Rockville, MD 20857, from 9 a.m. to 4 p.m., Monday through Friday. In addition, Delmarva Laboratories, Inc., has not been previously listed in 21 CFR 510.600(c)(1) and (c)(2) as sponsor of an approved application. That section is amended to add entries for the sponsor. The agency has carefully considered the potential environmental effects of this action. FDA has concluded that the action will not have a significant impact on the human environment, and that an environmental impact statement is not required. The agency's finding of no significant impact and the evidence supporting that finding, contained in an environmental assessment, may be seen in the Dockets Management Branch (address above) between 9 a.m. and 4 p.m., Monday through Friday. List of Subjects 21 CFR Part 510 Administrative practice and procedure, Animal drugs, Labeling, Reporting and recordkeeping requirements. 21 CFR Part 522 Animal drugs. Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR parts 510 and 522 are amended as follows: PART 510_NEW ANIMAL DRUGS 1. The authority citation for 21 CFR part 510 continues to read as follows: Authority: Secs. 201, 301, 501, 502, 503, 512, 701, 721 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e). 2. Section 510.600 is amended in the table in paragraph (c)(1) by alphabetically adding a new entry for Delmarva Laboratories, Inc., and in the table in paragraph (c)(2) by numerically adding a new entry ``059079'' to read as follows: §510.600 Names, addresses, and drug labeler codes of sponsors of approved applications. * * * * * (c) *␣*␣* (1) *␣*␣* 1Firm name and address 1Drug labeler code ␣ *␣␣␣␣*␣␣␣␣*␣␣␣␣*␣␣␣␣* Delmarva Laboratories, Inc., 2200 Wadebridge Rd., P.O. Box 525, Midlothian, VA 23113 059079 ␣ *␣␣␣␣*␣␣␣␣*␣␣␣␣*␣␣␣␣* (2) *␣*␣* 1Drug labeler code 1Firm name and address ␣ *␣␣␣␣*␣␣␣␣*␣␣␣␣*␣␣␣␣* 059079 Delmarva Laboratories, Inc., 2200 Wadebridge Rd., P.O. Box 525, Midlothian, VA 23113 ␣ *␣␣␣␣*␣␣␣␣*␣␣␣␣*␣␣␣␣* PART 522_IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS 3. The authority citation for 21 CFR part 522 continues to read as follows: Authority: Sec. 512 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360b). §522.900 [Amended] 4. Section 522.900 Euthanasia solution is amended in paragraph (b)(2) by removing the phrase ``No. 000061'' and adding in its place ``Nos. 000061 and 059079.'' Dated: March 21, 1994. Richard H. Teske, Acting Director, Center for Veterinary Medicine. [FR Doc. 94&hyph;7202 Filed 3&hyph;25&hyph;94; 8:45 am] BILLING CODE 4160&hyph;01&hyph;F
